Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Nieuwe signalen in kleine hersenen ontdekt
dec 2023 | Bewegingsstoornissen